SynthesisFrontiers in pharmacology2025
The protective role of curcumin in mitigating drug-induced toxicity in male reproductive system.
Synthesis in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Nano-formulated curcumin restores hypothalamic-pituitary-ovarian axis disturbance in cadmium-induced female reproductive toxicity.Open veterinary journal · 2026Article
- Exploratory Review on Male Fertility Potential of Acetyl-Eugenol: Mechanistic Insights, Experimental Evidence, and Therapeutic Prospects.Journal of experimental pharmacology · 2026Review
- Protective effects of curcumin against chemical-induced toxicity in the male reproductive system: a systematic review.Frontiers in pharmacology · 2026Review
- Targeting L-arginine/NO/cGMP/KFrontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Curcumin, a key bioactive component of turmeric ( Methods: A comprehensive search using multiple databases-PubMed Results: A total of twenty-five studies were reviewed for this analysis. Curcumin may help reduce the side effects of certain medications, including sertraline, diclofenac, paclitaxel, irinotecan, and methotrexate. Discussion: Research also indicates that curcumin possesses antioxidant properties, reduces inflammation, and aids sperm production. Most importantly, sperm motility, density, and morphology significantly improved in curcumin-treated groups compared to the control groups undergoing toxic pharmaceutical treatment. The dosage of curcumin used in these studies ranges from 50 to 200 mg/kg body weight. Conclusion: The available evidence suggests that curcumin may serve as a protective agent for male reproductive health against drug-induced damage, based on its diverse effects in mitigating oxidative stress and inflammation, which provide potential use in preserving reproductive health in males during pharmacological interventions. However, standardization of methodologies, along with more clinical evidence, is highly required before the practical application of findings related to treatment benefits can be made. Subsequent studies should focus on optimizing the use of this compound in combination with other pharmacological agents to enhance the protective effects of curcumin on male reproductive health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.